Contact Us

TMS Health Solutions Opens New Facility in Burlingame, First Clinic Focused Exclusively on Treating Depression

There will be three psychiatrists treating patients at the Burlingame clinic. Dr. DeGaetano, a Board Certified psychiatrist trained in psychopharmacology. Dr. Bumgarner, a Board Certified, Adult Psychiatrist, and Dr. Bermudes, Chief Medical Officer.

Given the widespread and growing impact of depression...we wanted to be laser-focused on treating patients with depression at this location.

    SAN FRANCISCO, CA, September 21, 2017 /24-7PressRelease/ -- TMS Health Solutions announced today that they have opened a new clinic in Burlingame focused exclusively on treating depression. "Given the widespread and growing impact of depression on society as well as the ongoing suffering of patients with mood disorders, we wanted to be laser-focused on treating patients with depression at this location," said Richard Bermudes, Chief Medical Officer.

There will be three psychiatrists treating patients at the Burlingame depression clinic. Dr. Noah DeGaetano is a Board Certified psychiatrist with received extensive training in psychopharmacology. Dr. Abel Bumgarner, joining the practice in the late Fall, is a Board Certified, Adult Psychiatrist with a passion for treating patients suffering from mood disorders. Dr. Richard Bermuders, Chief Medical Officer, will also be seeing patients out of the new location.

The depression clinic, located at 1860 El Camino Real, Suite 250, is close to both Millbrae Bart and Caltrain stations and directly located across the street from Mills-Peninsula Medical Center, a Sutter Healthcare provider. "Convenient patient accessibility for people suffering from clinical depression is of the utmost importance for us. It's our mission to focus on treating patients with depression and increase overall access to Transcranial Magnetic Stimulation, a highly effective treatment. One way we're able to do this is by opening new locations with best-in-class healthcare providers," said Brad Hummel, CEO, TMS Health Solutions.

As depression is the second greatest cause of disability worldwide with an estimated 350 million people affected, TMS Health Solutions' team of clinicians and staff have dedicated their lives to treating people with mental health conditions, with a focus on helping people with treatment-resistant depression, and providing the most advanced treatments available.

Burlingame Clinicians:
Dr. Richard Bermudes is a Board Certifed in Adult Psychiatry and Family Medicine with other twenty years' experience caring for patients. He received his medical degree from the University of California, San Diego, and served as Chief Resident for the Family Medicine/Psychiatry Combined Program at the University of Cincinnati. He founded a group practice, now known as TMS Health Solutions, in 2007, and became the first provider to offer TMS for treatment of depression in the Sacramento, CA, area. He recently edited a book focused on the clinical applications of TMS. As Chief Medical Officer, he continues to lead the practice on educating the public and clinicians on mental health issues, depression and using TMS for treatment.

Dr. Abel Bumgarner is a Board Certified psychiatrist with a passion for treating patients suffering from mood disorders. He earned his medical degree from Thomas Jefferson University in Philadelphia and completed his general psychiatry residency training at the University of Maryland/Sheppard Pratt Hospital in Baltimore. During his training, he worked with patients who suffered from a wide variety of psychiatric disorders with symptoms from depression and anxiety. He has a well-rounded, wide breadth of experience and will join TMS Health Solutions in October of 2017.

Dr. Noah DeGaetano is a Board Certified psychiatrist who specializes in treating patients with Major Mood Disorder (MDD), also known as "clinical depression." He has extensive training in psychopharmacology and also finds that Transcranial Magnetic Stimulation (TMS) may assist the over 40% of patients who may not find relief with psychotherapy and/or medication. He completed his medical degree and psychiatric residency at Mount Sinai School of Medicine in New York City, where he also served as Chief Resident. He was Resident Clinic Director at the VA Palo Alto Healthcare System and was a clinical instructor at the Stanford School of Medicine in the Department of Psychiatry for five years. He joined TMS Health Solutions in May of 2017.

About Transcranial Magnetic Stimulation (TMS) Therapy:
Cleared by the FDA in 2008, TMS is a drug-free, non-invasive therapy for patients who suffer from treatment-resistant depression. It is administered in a physician's office in an outpatient setting. By using a MRI-strength magnetic field to stimulate the prefrontal cortex of the brain, the core symptoms of major depression can be relieved. Unlike antidepressants or Electroconvulsive Therapy (ECT), patients undergoing TMS therapy experience minimal side effects.

About TMS Health Solutions:
Headquartered in San Francisco, California, TMS Health Solutions clinics specialize in the delivery of TMS therapy for patients suffering from treatment-resistant depression. Additionally, the clinics provide traditional treatment for mood disorders. TMS Health Solutions is led by Dr. Richard Bermudes and Dr. Karl Lanocha, two of the nation's leading experts on using TMS therapy as an innovative treatment for depression.


# # #

Read more Press Releases from Natalie Brown:


Comment on this story...

Share This Story


Email this Story

Contact Information


Natalie Brown
TMS Health Solutions

San Francisco, CA
USA
Voice: 415.671.6819 x1154
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us:

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.